An Implementation Roadmap to Accelerate Academic Clinical Cancer Research in Portugal: A Multistakeholder Perspective

Authors

  • Ana Sofia V. Carvalho Public and Occupational Health. Amsterdam UMC, location University of Amsterdam. Amsterdam. https://orcid.org/0000-0002-1640-9957
  • Fábio Cardoso Borges European Organisation for Research and Treatment of Cancer (EORTC). Brussels. https://orcid.org/0000-0001-8496-9211
  • Maria-João Cardoso Breast Unit. Champalimaud Foundation. Lisbon. & Faculty of Medicine. Universidade de Lisboa. Lisbon. https://orcid.org/0000-0002-8137-3700
  • Júlio Oliveira Portuguese Oncology Institute of Porto (IPO-PORTO). Porto. https://orcid.org/0000-0002-9576-3486
  • José Pais Silva European Organisation for Research and Treatment of Cancer (EORTC). Brussels. https://orcid.org/0000-0002-1036-8699
  • Sónia Carvalho Agency for Clinical Research and Biomedical Innovation (AICIB). Porto.
  • Luís Costa Faculty of Medicine. Universidade de Lisboa. Lisbon. & Clinical Research Centre. Unidade Local de Saúde Santa Maria. Lisbon. & Unidade Local de Saúde Santa Maria. Lisbon. https://orcid.org/0000-0002-4782-7318
  • Isabel Fernandes National Program for Oncological Diseases. Directorate-General of Health. Lisbon. & EpiDoC Unit. Nova Medical School. Universidade NOVA de Lisboa. Lisbon. https://orcid.org/0000-0003-4032-7713
  • Dora Gomes Portuguese Oncology Institute of Porto (IPO-PORTO). Porto. & Radiation Oncology Speciality College. Portuguese Medical Association. Lisbon. https://orcid.org/0000-0001-8159-5867
  • Mónica Gomes North Branch. Portuguese Cancer League. Lisbon. https://orcid.org/0000-0001-9947-5775
  • Tamara Milagre EVITA. Lisbon.
  • Sónia Rego EuropaColon Portugal. Porto.
  • Marta Soares Portuguese Oncology Institute of Porto (IPO-PORTO). Porto. & Portuguese Association for Cancer Research. Porto. https://orcid.org/0000-0002-6071-3673
  • Carlos Sottomayor EuropaColon Portugal. Porto. & Medical Oncology Speciality College. Portuguese Medical Association. Lisbon. & Unidade Local de Saúde Matosinhos. Matosinhos. https://orcid.org/0000-0002-4103-2039
  • Ana Joaquim European Organisation for Research and Treatment of Cancer (EORTC). Brussels. https://orcid.org/0000-0001-7064-9639
  • Nuno Sousa Agency for Clinical Research and Biomedical Innovation (AICIB). Porto. https://orcid.org/0000-0002-8755-5126
  • José Luís Passos Coelho Portuguese Society of Oncology. Coimbra. & Hospital da Luz Lisboa. Lisbon. https://orcid.org/0000-0002-9458-8604

DOI:

https://doi.org/10.20344/amp.23479

Keywords:

Academic Medical Centers, Biomedical Research, Clinical Trials as Topic, Health Policy, Medical Oncology, Neoplasms, Portugal, Research Personnel

Abstract

n/a.

Downloads

Download data is not yet available.

References

Leary A, Besse B, André F. The need for pragmatic, affordable, and practice-changing real-life clinical trials in oncology. Lancet. 2024;403:406-8. DOI: https://doi.org/10.1016/S0140-6736(23)02199-2

Organisation for Economic Co-operation and Development. Tackling the impact of cancer on health, the economy and society. Paris: OECD; 2024.

Autoridade Nacional do Medicamento e Produtos de Saúde IP. Evolução anual (2005 a 2022) – ensaios clínicos ao abrigo da diretiva 2001/20 de 04 de abril. [cited 2024 Nov 09]. Available from: https://www.infarmed.pt/documents/15786/6307769/2005-4T2022_PT/051e8cdc-56a5-5405-7921-c04a3a7b93ff.

Citeline Custom Intelligence. EU Benchmark Clinical Research. 2023. [cited 2025 Mar 20]. Available from: https://dcrfonline.nl/wp-content/uploads/sites/12/2023/12/EU-Benchmark-Clinical-Research.pdf.

Ferreira JP, Leite-Moreira A, Da Costa-Pereira A, Soares AJ, Robalo-Cordeiro C, Jerónimo C, et al. Investigação clínica da iniciativa do investigador em Portugal: identificação de problemas e propostas para melhoria. Acta Med Port. 2023;36:305-8. DOI: https://doi.org/10.20344/amp.19333

Borges-Carneiro F, Torre Souto M, Silva I, Leão Moreira P, Ferraz de Oliveira P, Lopes DJ, et al. Clinical trials in Portugal: past and future. position paper from the colleges of clinical pharmacology and pharmaceutical medicine. Acta Med Port. 2024;37:585-8. DOI: https://doi.org/10.20344/amp.21371

Nilsen P. Making sense of implementation theories, models and frameworks. Implement Sci. 2015;10:1-13. DOI: https://doi.org/10.1186/s13012-015-0242-0

Flottorp SA, Oxman AD, Krause J, Musila NR, Wensing M, Godycki-Cwirko M, et al. A checklist for identifying determinants of practice: a systematic review and synthesis of frameworks and taxonomies of factors that prevent or enable improvements in healthcare professional practice. Implement Sci. 2013;8:1-11. DOI: https://doi.org/10.1186/1748-5908-8-35

Belgian Health Care Knowledge Centre (KCE). 2024 - BeNeFIT4: Fourth BeNeFIT call for comparative effectiveness studies with ZonMw. 2024. [cited 2025 Mar 13]. Available from: https://kce.fgov.be/en/kce-trials/calls/2024-benefit4-fourth-benefit-call-for-comparative-effectivenessstudies-with-zonmw.

Roquette C, Crisóstomo S, Milagre T, Ribeiro RS, Pedro AR, Valente A. Patient organisations’ views, motivations and experiences on patient involvement in cancer research: a pilot study in Portugal. BMJ Open. 2024;14:e077444. DOI: https://doi.org/10.1136/bmjopen-2023-077444

Downloads

Published

2026-01-02

How to Cite

1.
V. Carvalho AS, Cardoso Borges F, Cardoso M-J, Oliveira J, Pais Silva J, Carvalho S, Costa L, Fernandes I, Gomes D, Gomes M, Milagre T, Rego S, Soares M, Sottomayor C, Joaquim A, Sousa N, Passos Coelho JL. An Implementation Roadmap to Accelerate Academic Clinical Cancer Research in Portugal: A Multistakeholder Perspective. Acta Med Port [Internet]. 2026 Jan. 2 [cited 2026 Jun. 25];39(1):8-13. Available from: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/23479

Issue

Vol. 39 No. 1 (2026): January

Section

Perspective

License

Copyright (c) 2025 Acta Médica Portuguesa

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.

It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.

Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.

After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.

Crossref
Scopus
Google Scholar
Europe PMC